The price you pay for Carvykti may depend on factors such as your location and your insurance plan. Financial assistance may be available to help you with the cost of this treatment.

Carvykti is used in adults to treat multiple myeloma that either:

Carvykti belongs to a group of drugs called CAR T-cell therapy.

Several factors can affect the price you’ll pay for Carvykti. These include:

  • your treatment plan
  • your insurance coverage
  • your location
  • the cost of the visit to a healthcare professional to receive Carvykti
  • available financial assistance for Carvykti (see the “Financial and insurance assistance” section)

To find out your cost for Carvykti, talk with your doctor, pharmacist, or insurance provider (if you have insurance).

Carvykti is a biologic drug, which means it’s made from parts of living organisms. It doesn’t come in a biosimilar form. Biosimilars are like generic drugs, but unlike generics (which are made for nonbiologic drugs), biosimilars are made for biologics.

Why is there such a cost difference between biologic drugs and biosimilar drugs?

Biologic drugs can be expensive because of the research and testing needed to ensure their safety and effectiveness. The manufacturer of a biologic drug can sell it exclusively for up to 12 years. When the biologic drug’s patent expires, other drugmakers can create biosimilar versions. This competition in the market may lead to lower costs for biosimilars. And because biosimilars are very similar to biologic drugs, they don’t need to be studied again. This can also lead to lower costs for biosimilars.

If you need financial support to pay for Carvykti or help understanding your insurance coverage, assistance is available. For example:

  • A program called MyCARVYKTI Patient Support Program is available for Carvykti. For more information and to find out whether you’re eligible for support, call 800-559-7875 or visit the program website.
  • Some websites provide details about drug assistance programs, ways to make the most of your insurance coverage, and links to savings cards and other services. Two such websites are:

You may want to consider the following information if you have insurance and receive Carvykti treatment.

Prior authorization: If you have insurance, your insurance company may require prior authorization before it covers Carvykti. This means the company and your doctor will discuss the drug in regard to your treatment. The insurance company will then determine whether Carvykti is covered. If a drug requires prior authorization but you start treatment without the prior approval, you could pay the full cost of the medication. Be sure to ask your insurance company whether Carvykti requires prior authorization.

Type of insurance coverage: Carvykti is given by your doctor or another healthcare professional. If you have insurance, the price of your Carvykti treatment may be billed through your medical coverage instead of the prescription drug portion of your insurance plan. This depends on your specific insurance plan and where you receive your Carvykti treatment, such as at your doctor’s office, an infusion clinic, or a hospital. If you have questions about this process, contact your doctor or your insurance provider.

Disclaimer: Healthline has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.